CSIMarket
 


Odonate Therapeutics, Inc.  (ODT)
Other Ticker:  
 

Odonate Therapeutics's Working Capital Ratio

ODT's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




ODT Working Capital Ratio (Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
Y / Y Current Liabilities Change 2118.42 % -9.84 % -95.72 % 2015.98 % 90.01 %
Y / Y Current Assets Change 62641.2 % 0.78 % -99.94 % 54583.28 % 143.96 %
Working Capital Ratio MRQ 8.41 0.2 0.3 7.68 0.3
Overall Ranking # # # # #
Seq. Current Liabilities Change 2491.75 % 129.77 % -97.72 % 1532.24 % 5.34 %
Seq. Current Assets Change 109868.68 % 53.28 % -99.91 % 42029.63 % 76.65 %



Working Capital Ratio third quarter 2019 Comment
Odonate Therapeutics's Current Assets grew by 109868.68 % in III. Quarter sequntially, faster than Current Liabilities, this led to improvement in Odonate Therapeutics's Working Capital Ratio to 8.41, Working Capital Ratio remained below Odonate Therapeutics, Inc. average.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Working Capital Ratio than Odonate Therapeutics in third quarter 2019. While total ranking remained unchanged compare to previous quarter at no. .

Explain Working Capital Ratio
Where is ODT most successful ?
Working Capital Ratio ODT on the trailing twelve month basis
Working Capital Ratio third quarter 2019 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 5
Healthcare Sector # 120
Overall Market # 346


Working Capital Ratio Statistics
High Average Low
20.5 2.9 0.11
(Mar 31 2018)   (Jun 30 2012)




Financial Statements
Odonate Therapeutics's Current Liabilities $ 25 Millions Visit ODT's Balance sheet
Odonate Therapeutics's Current Assets $ 208 Millions Visit ODT's Balance sheet
Source of ODT's Sales Visit ODT's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2019, within Laboratory Analytical Instruments Industry Working Capital RatioSep 30 2019 MRQ Current AssetsSep 30 2019 MRQ Current Liabilities
Accelerate Diagnostics, Inc.  21.93 $ 134.395  Millions$ 6.128  Millions
Bioforce Nanosciences Holdings, Inc.  11.65 $ 0.053  Millions$ 0.005  Millions
Biosig Technologies, Inc.  10.62 $ 12.883  Millions$ 1.213  Millions
Co-diagnostics, Inc.  10.16 $ 3.084  Millions$ 0.304  Millions
Odonate Therapeutics, Inc.  8.41 $ 208.196  Millions$ 24.747  Millions
Precipio, Inc.  6.94 $ 120.837  Millions$ 17.404  Millions
Illumina, Inc.  6.82 $ 4,222.000  Millions$ 619.000  Millions
Lifeloc Technologies, Inc  5.24 $ 5.826  Millions$ 1.112  Millions
Htg Molecular Diagnostics, Inc  5.21 $ 43.864  Millions$ 8.420  Millions
Sensus Healthcare, Inc.  5.01 $ 32.731  Millions$ 6.535  Millions
Eyepoint Pharmaceuticals, Inc.  4.54 $ 47.061  Millions$ 10.368  Millions
Zynex Inc  4.12 $ 18.638  Millions$ 4.519  Millions
Precision Optics Corporation, Inc.  3.35 $ 4.748  Millions$ 1.416  Millions
Standard Diversified Inc.  3.19 $ 234.589  Millions$ 73.459  Millions
Viveve Medical, Inc.  3.05 $ 19.084  Millions$ 6.248  Millions
Integra Lifesciences Holdings Corp  2.92 $ 883.813  Millions$ 302.641  Millions
Harvard Bioscience Inc  2.71 $ 52.289  Millions$ 19.273  Millions
Misonix Inc  2.56 $ 35.495  Millions$ 13.865  Millions
Reflect Scientific Inc  2.26 $ 0.687  Millions$ 0.305  Millions
My Size, Inc.  2.15 $ 3.254  Millions$ 1.511  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FMFG's Profile

Stock Price

FMFG's Financials

Business Description

Fundamentals

Charts & Quotes

FMFG's News

Suppliers

FMFG's Competitors

Customers & Markets

Economic Indicators

FMFG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071